15585-43-0 Usage
Description
Rivanicline, also known as an oil-based chemical compound, is a potential pharmaceutical candidate with promising applications in the treatment of neurological disorders. It is currently being investigated as a nicotinic agonist with central nervous system (CNS) selectivity, which may contribute to its therapeutic effects.
Uses
Used in Pharmaceutical Industry:
Rivanicline is used as a potential drug for the treatment of senile dementia of the Alzheimer's type. Its application is based on its ability to act as a nicotinic agonist with CNS selectivity, which may help improve cognitive functions and slow down the progression of the disease in patients.
Additionally, due to its oil-based chemical properties, rivanicline may also be utilized in the development of novel drug delivery systems, potentially enhancing its bioavailability and therapeutic outcomes when combined with other treatments or formulations.
Check Digit Verification of cas no
The CAS Registry Mumber 15585-43-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,5,8 and 5 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 15585-43:
(7*1)+(6*5)+(5*5)+(4*8)+(3*5)+(2*4)+(1*3)=120
120 % 10 = 0
So 15585-43-0 is a valid CAS Registry Number.
15585-43-0Relevant articles and documents
Dealkenylative Alkenylation: Formal σ-Bond Metathesis of Olefins
Kwon, Ohyun,Sadykhov, Gusein,Swain, Manisha,Wang, Ruoxi
supporting information, p. 17565 - 17571 (2020/09/01)
The dealkenylative alkenylation of alkene C(sp3)?C(sp2) bonds has been an unexplored area for C?C bond formation. Herein 64 examples of β-alkylated styrene derivatives, synthesized through the reactions of readily accessible feedstock olefins with β-nitrostyrenes by ozone/FeII-mediated radical substitutions, are reported. These reactions proceed with good efficiencies and high stereoselectivities under mild reaction conditions and tolerate an array of functional groups. Also demonstrated is the applicability of the strategy through several synthetic transformations of the products, as well as the syntheses of the natural product iso-moracin and the drug (E)-metanicotine.